PATENT CLAIM ANALYSIS

Application Number: 16012992
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "001890"]

Abstract:
Described are assay methods, modules and kits useful in the detection, treatment and/or prevention of dementia and related conditions, including but not limited to Alzheimer's disease and mild cognitive disorders.

Claim (Index 15):
The method of  claim 14  wherein said method further comprises comparing said level(s) of said first biomarker and said at least one additional biomarker(s) in said two or more test samples to a level of said first biomarker and said at least one additional biomarker(s) in a normal control sample and determining the presence and/or absence of plaques in the brain of said patient based on said comparison.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 94.0
- Lexical Diversity: 1.12903
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12867479', '12799484', '13874052', '14200020', '10982545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7092420595820339
- 35 USC 102 Novelty (BERT): 0.5131745225502019
- Combined Prediction Score: 0.6896353058788507
- Mean Citation Score: 253.80111
- Max Citation Score: 263.87994
- Similarity Product: 187.6197292733073

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test